Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Infliximab in Treatment Resistant Major Depression
NCT00463580Phase 4Completed
- Sponsor
- Emory University
- Start
- Dec 2008
- Primary completion
- Jun 2011
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of infliximab in major depressive disorder (MDD), sponsored by Emory University. Started Dec 2008; status: completed.
02
Drugs
infliximab
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00463580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463580.